Mar 19, 2015

Microtechnology industry reserved about TTIP in its present design


Source: © Zerbor - Fotolia.com
Mar 19, 2015
The proposed Transatlantic Trade and Investment Partnership (TTIP) between the European Union and the US is causing mixed feelings in the European microtechnology industry. The companies appreciate the potential benefits of the free trade agreement, but they rather disapprove of it in its considered design.
 
In the annual economic data survey of the IVAM Microtechnology Network in February 2015, more than two thirds (69%) of respondents presumed that their company would benefit from TTIP. A larger proportion (75%) think that TTIP would have a positive impact on the economy of their country. Especially companies with high export quotas hope to gain economic profit from the free trade agreement.
 
The possible benefits most often mentioned by the responding companies are an elimination of tariffs and a reduction of administrative barriers. SME that have already entered the US market are more often looking forward to more transparent import regulations and easier access to orders than those without US market activities.
 
However, some aspects of TTIP, especially IP and investment protection, make the industry doubt the all-over benefit for European high-tech SME. The companies are especially bothered by differences in the patent laws of the US and Europe that would put European companies at a disadvantage, and the uncertainties concerning investment protection – a topic which is still waiting to be negotiated. TTIP might gain a better reputation with the European microtechnology industry, if the goals were communicated more actively, negotiations became more transparent and controversial issues were resolved with priority.



69% of microtechnology companies think that they would benefit from TTIP, 75% expect a positive impact on the economy.
Source: IVAM Research

Recommended articles

Apr 2, 2025

Cancer diagnostics is at a turning point: new technologies are fundamentally changing how we recognize, understand and treat diseases. This …

Apr 1, 2025

The technical program for the IVAM Hightech Summit 2025, taking place on May 21–22 at Signal Iduna Park in …

Feb 18, 2025

When the current stage of the AI Act comes into force, all companies that use artificial intelligence must ensure that …

Recommended events

Sep 9 - 11, 2026
Manufacturing Processes for Medical Technology
Feb 4 - 6, 2026
Discover the Future of Photonics with IVAM
Feb 3 - 5, 2026
Medical Design & Manufacturing - IVAM presents Micro Nanotech Area in Hall C